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Background: A recent, large genome-wide association study (GWAS) of European ancestry individuals has
identified multiple genetic variants influencing serum lipids. Studies of the transferability of these associations to
African Americans remain few, an important limitation given interethnic differences in serum lipids and the
disproportionate burden of lipid-associated metabolic diseases among African Americans.
Methods: We attempted to evaluate the transferability of 95 lipid-associated loci recently identified in European
ancestry individuals to 887 non-diabetic, unrelated African Americans from a population-based sample in the
Washington, DC area. Additionally, we took advantage of the generally reduced linkage disequilibrium among
African ancestry populations in comparison to European ancestry populations to fine-map replicated GWAS signals.
Results: We successfully replicated reported associations for 10 loci (CILP2/SF4, STARD3, LPL, CYP7A1, DOCK7/
ANGPTL3, APOE, SORT1, IRS1, CETP, and UBASH3B). Through trans-ethnic fine-mapping, we were able to reduce
associated regions around 75% of the loci that replicated.
Conclusions: Between this study and previous work in African Americans, 40 of the 95 loci reported in a large
GWAS of European ancestry individuals also influence lipid levels in African Americans. While there is now evidence
that the lipid-influencing role of a number of genetic variants is observed in both European and African ancestry
populations, the still considerable lack of concordance highlights the importance of continued ancestry-specific
studies to elucidate the genetic underpinnings of these traits.
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The distribution of serum lipid concentrations has well-
established clinical utility as a risk factor for a range of
metabolic diseases, including cardiovascular disease (CVD)
and type 2 diabetes (T2D). As such, great effort has gone
into uncovering the genetic epidemiology of serum lipids,
including a recent meta-analysis of 46 genome-wide stud-
ies comprising more than 100,000 individuals of European
ancestry [1]. This study yielded 95 loci significantly asso-
ciated with at least one of four serum lipid traits:
high-density lipoprotein cholesterol (HDL), low-density
lipoprotein cholesterol (LDL), triglycerides (TG), or total
cholesterol (TC). Understanding the genetic underpinnings* Correspondence: adeyemoa@mail.nih.gov; rotimic@mail.nih.gov
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reproduction in any medium, provided the orof risk factors for metabolic disorders is particularly rele-
vant for African Americans, who experience a dispropor-
tionate burden of CVD mortality [2,3] and T2D [4]; this
disparity is projected to continue [5]. While replication
of some of the lipid-associated loci identified among
European ancestry individuals has been reported for
African Americans of the NHLBI’s CARe consortium [1,6]
and the PAGE study [7], several limitations to these ana-
lyses warrant further evaluation. First, 20 of the lead asso-
ciations in the 95 loci have not yet been investigated in
African Americans (primarily due to the lack of avail-
ability of TC in these cohorts). Second, for all but a few
associations that have been investigated, exact replication
(i.e., look-up of only the reported index SNP) was
attempted. Given the generally greater linkage disequilib-
rium (LD) among European-ancestry individuals, it is
expected that index SNPs tag larger regions than theyral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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functional variant tagged by the index SNP in European
ancestry individuals might not be in LD with the same
SNP in African-ancestry individuals, motivating different
analytical strategies (i.e., “local” replication, described
below). In the present study, we used more robust analytic
strategies to investigate the transferability of reported gen-
etic associations for serum lipids to African Americans.
We also exploited these interethnic differences in LD to
conduct fine-mapping of the replicated loci.Table 1 Characteristics of study sample
Characteristic Men Women
N 374 (42%) 513 (58%)
Age (years) 45.5 ± 12.4 46.4 ± 13.3
Body mass index (kg/m2) 28.4 ± 7.3 31.5 ± 8.8
High density lipoprotein (mg/dL) 51.7 ± 17.5 54.8 ± 16.3
Low density lipoprotein (mg/dL) 113.6 ± 38.1 119.6 ± 38.7
Total cholesterol (mg/dL) 189.2 ± 41.4 196.8 ± 43.2
Triglycerides (mg/dL) 108.6 ± 61.4 100.1 ± 60.2
Data are number (percent) or mean ± standard deviation.Methods
Ethical approval for this study was obtained from the
Howard University Internal Review Board. Written
informed consent was provided by all participants. The
Howard University Family Study (HUFS) is a population-
based study of African Americans in the Washington, DC
metropolitan area [8]. Unrelated, non-diabetic participants
were included if they were not using lipid-lowering medi-
cation. Serum lipids were assayed using fasting blood sam-
ples (>8 hours), and concentrations were determined
enzymatically on a Cobas Integra 400 Analyzer (Roche
Diagnostics, Indianapolis, IN). The intra-assay coeffi-
cients of variation (CV) for lipid assays indicate con-
sistent performance (TC, LDL, and HDL, CV <1.5%; TG,
CV < 3.0%).
Genome-wide genotyping was performed using the Affy-
metrixW Genome-Wide Human SNP Array 6.0. Genotype
calls were made using Birdseed, version 2 [9]. SNPs were
excluded if they had a call rate <95% (n = 41,885), a minor
allele frequency <0.01 (n = 19,154) or a Hardy-Weinberg
equilibrium (HWE) test p-value <1 × 10-3 (n = 6,317). A
total of 808,465 autosomal SNPs passed these filters. The
average call rate for this set of SNPs was 99.55%, with con-
cordance of blind duplicates of 99.74%. A check for popula-
tion stratification was conducted using non-parametric
clustering of genotypes as previously described [10].
Power calculations were performed using QUANTO
[11]. When the MAF was at least 0.05, this study was
adequately powered (power > 90%) to detect associations
of the range observed in the prior publication for all
traits except for HDL (power < 50% to detect the mini-
mum effect size observed previously). With a MAF of
0.01, the power remained sufficient across the range of
TG, but was low (≤50%) to detect the minimum effect
sizes observed for each of the other traits. Imputation
was performed using the MACH algorithm as previ-
ously described [8] (with 1000 Genomes reference data,
http://www.1000genomes.org/). SNPs were excluded if
they had a missingness rate ≥10%, Hardy-Weinberg test
p-value <1 × 10-3, or a minor allele frequency <0.01.
Imputed SNPs for which no rsid is currently available are
described with a “chromosome:position” nomenclature(position refers to NCBI36 build). After quality control fil-
ters, 5,396,780 markers were included in the analysis.
Association analysis for the log-transformed lipid vari-
ables was performed using PLINK v1.07 [12] under an
additive genetic model with adjustment for age, sex,
body mass index (BMI), and the first 2 PCs of the geno-
types (computed using EIGENSTRAT [13]). The appro-
priate number of PCs necessary to adjust for population
substructure in HUFS has been previously determined
[14]. Replication was attempted using two strategies.
First, we investigated the exact SNPs that were previ-
ously identified [1]. A SNP was considered replicated if
the direction of effect was consistent and the association
p-value was ≤0.05 [15]. Second, we looked at all SNPs
that were in LD with the reported SNPs in the CEU
population, using a search window of ±250 kb from
the index SNP with r2 ≥0.30 (“local replication”; for
further discussion, see [16]). P-values obtained in the
local replication were corrected for the effective degrees
of freedom within an LD block containing the reported
SNP [17], and an adjusted p-value 0.05 was considered
statistically significant.
To take advantage of the generally decreased haplotype
size in African ancestry populations, fine-mapping of repli-
cated signals was attempted using the following strategies:
inspection of regional plots of association to identify
SNPs with a stronger signal than the index SNP in HUFS
(LocusZoom 1.1, http://csg.sph.umich.edu/locuszoom/)
and comparison of haplotype block structure between the
CEU and YRI for SNPs of interest (Haploview 4.2, http://
www.broadinstitute.org/haploview/haploview). Finally, we
examined the other SNPs on the array and the imputed
SNPs for any association with a genome-wide significant
p < 2.5 × 10-8 [18].
Results
The study sample comprised 887 African Americans
(374 men, 513 women), with a mean age of 46 years and a
mean BMI of 28 kg/m2 in men and 31.5 kg/m2 in women
(Table 1). Of the 95 previously identified lipids-associated
index SNPs, 86 were successfully genotyped or imputed in
HUFS (Figure 1). After quality control, 51 SNPs were
Exact Local
95 Loci from  
previous report
9 loci dropped 
Attempted:
Not Genotyped 




88 Loci not  
replicated exactly
569 SNPs in LD with 
index SNPs among CEU




Transferable: 7 loci 3 loci
Reduced Region of 
Interest Around Signal:
8 loci







Figure 1 Summary of methods.
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fully replicated 7 of these 51 previously identified lipids-
associated loci: CILP2/SF4, STARD3, LPL, CYP7A1,
DOCK7/ANGPTL3, APOE, and SORT1 (Table 2). A
comparison of the allele frequencies in those of African
and European ancestry is provided for those SNPs that did
not replicate (Additional file 1).
We replicated additional SNPs using an LD-based
local replication strategy. We identified 569 SNPs thatTable 2 Exact replication of previously reported GWAS associ






rs10401969 19 19268718 G (0.17, 0.10) CILP2/SF4
rs11869286 17 35067382 G (0.26, 0.68) STARD3
rs12678919 8 19888502 G (0.11, 0.12) LPL
rs2081687 8 59551119 T (0.22, 0.33) CYP7A1
rs2131925 1 62798530 T (0.37, 0.68) ANGPTL3
rs4420638 19 50114786 C (0.21, 0.18) APOE
rs629301 1 109619829 G (0.36, 0.30) SORT1
1Teslovich et al., Nature, 2010; 2The minor allele for HUFS is the major allele in prevwere in LD among the CEU with SNPs at the 88 loci that
did not replicate exactly (Figure 1). Of these, 530 were
genotyped or imputed in HUFS. After quality control, 389
SNPs representing 62 loci were included in the analysis.
An additional 3 loci were replicated: IRS1, CETP, and
UBASH3B (Table 3). In total, we were able to evalu-
ate 82 of the 95 reported loci by either exact or local
replication, and 10 of these (12%) showed significant
association in HUFS.ations1 in a cohort of African Americans
Trait HUFS Previous Report
Beta (SE) P-value Beta (SE) P-value
TG −8.3 (2.8) 0.006 −7.8 (0.8) 1.6 x 10-29
HDL 2.1 (0.9) 0.02 −0.5 (0.08)2 2.8 x 10-14
TG −9.0 (4.4) 0.01 −13.6 (0.6) 1.5 x 10-115
LDL 5.2 (2.5) 0.04 0.95 (0.2) 3.9 x 10-9
TC 4.5 (2.3) 0.04 −2.6 (0.2)2 4.9 x 10-41
HDL −2.3 (0.9) 0.02 −1.1 (0.1) 4.4 x 10-21
LDL −5.4 (1.9) 0.005 −5.7 (0.2) 9.7 x 10-171
ious report, thus the direction of effect should be reversed for comparison.











Trait Local SNP Values)
Beta (SE) P-value2
rs2972146 rs2943652 1 2 226816690 C (0.38, 0.40) IRS1 HDL 3.0 (1.1) 0.01
rs3764261 rs173539 1 16 55545545 T (0.30, 0.37) CETP HDL 4.3 (1.2) 0.0003
rs1800775 0.5 16 55552737 C (0.45, 0.49) CETP HDL −2.5 (1.0) 0.03
rs4783961 0.6 16 55552395 A (0.37, 0.51) CETP HDL 4.6 (1.3) 0.0009
rs7941030 rs6589939 0.9 11 122023735 G (0.35, 0.39) UBASH3B TC −6.7 (2.1) 0.005
1Teslovich et al., Nature, 2010; 2P-values have been adjusted for the effective degrees of freedom within the LD window surrounding the index SNP.
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generally reduced LD across the genomes of those of
African ancestry resulted in finer mapping of the sig-
nals observed among European ancestry populations
(Figure 1, Table 4). In the case of reported SNP rs12678919
(downstream of LPL), stronger association was observed
for LPL intronic SNP rs12679834 (p = 0.001). While these
two SNPs are in the same 53 kb haplotype block among
the CEU, rs12678919 is not associated with a haplo-
type block in the YRI and rs12679834 is associated
with a much smaller haplotype block (8 kb). This re-
sult suggests that the causal SNP is more closely
linked with rs12679834 than rs12678919, and dramat-
ically reduces the region for further investigation from
53 kb to 8 kb (Figure 2). Similarly, rs7941030 (UBASH3B)
was not associated with TC in HUFS (p = 0.10), but
rs6589939, which was in the same 40 kb haplotype block
in the CEU, was (p = 0.005). Among the YRI, neither
rs6589939 nor rs7941030 was in a haplotype block. In thisTable 4 Summary of fine mapping of replicated loci







rs10401969 96 kb 88 kb
rs11869286 19 kb 49 kb
rs12678919 53 kb Not in block Higher peak
CEU, not in
rs2081687 17 kb 1 kb Rs10088541
index SNP =
rs2131925 298 kb 201 kb
rs2972146 (rs2943652) Index SNP n
comparison
rs3764261 (rs173539) Index SNP n
comparison
rs3764261 (rs1800775) Index SNP n
comparison
rs3764261 (rs4783961) Index SNP n
comparison
rs4420638 Not in block Not in block
rs629301 16 kb 468 bp (Figure 4)
rs7941030 (rs6589939) 40 kb Not in block Higher peak
block as thestudy sample, an intronic SNP in NSMAF, rs10088541,
had a lower p value than index SNP rs2081687 (nearest
CYP7A1; p = 7.5 × 10–5 vs. 0.04). While these SNPs are
correlated among the CEU (r2 = 0.75), they are not
correlated in the HUFS samples (r2 = 0.03): the causal
SNP may be more closely linked to rs10088541 (Figure 3).
The replication of rs629301 (SORT1) in HUFS signifi-
cantly reduces the region of interest for this signal. While
this SNP is in a 16 kb haplotype block in the CEU, the
block is reduced to less than 500 bp among the YRI
(Figure 4).
A search for other hits in the full set of genotyped and
imputed SNPs showed that no SNPs reached genome-
wide significance (Additional files 2,3,4,5). The top SNPs
were: chr16:50157331 near the gene HEATR3 (associated
with increased TG, p = 5.9 × 10-8), rs711794 near ZAK
(associated with decreased LDL, p = 6.3 × 10-8), and
rs1047163, a 3’ UTR variant near HS1BP3 (associated
with decreased HDL, p = 6.4 × 10-8).is rs12679834 (p = 0.0010), in same haplotype block as rs12678919 in
YRI. (Figure 2)
is a higher peak nearby (p = 7.5 x 10-5). R2 between rs10088541 and
0.75 among CEU, but only 0.03 in HUFS. (Figure 3)
ot successfully genotyped or imputed in HUFS: no fine-mapping
s possible.
ot successfully genotyped or imputed in HUFS: no fine-mapping
s possible.
ot successfully genotyped or imputed in HUFS: no fine-mapping
s possible.
ot successfully genotyped or imputed in HUFS: no fine-mapping
s possible.
is at SNP rs6589939 (p = 0.005 vs. p = 0.10), which is in the same 40 kb
index SNP among CEU.
rs1267934
rs12678919
Figure 2 Fine mapping of rs12678919. LocusZoom output for the association of rs12678919 and TG, showing the association of nearby LPL
SNP rs1267934, as well.
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We identified 10 loci that influence lipid levels in this co-
hort of African Americans. Of these, 7 were identified
through testing the reported SNP while an additional 3
loci were identified using an LD-based strategy employed
to account for the potential non-transfer of association
signals across populations with different ancestral back-
ground [19]. Teslovich et al. assessed the generalizability
of their findings by attempting replication in ~8,000rs2081687
Figure 3 Fine mapping of rs2081687. LocusZoom output for the associa
nearby SNP rs10088541.African Americans in the CARe consortium [1]. Of the 75
out of 95 loci for which the index SNP-trait associ-
ation was investigated, 29 successfully replicated (see
Supplementary Table 11 of that paper). A subset of
these loci, along with replication of other lipid GWAS
signals in the CARe African Americans, was also
reported by Lettre et al. [6]). The PAGE study, which
included ~9,000 African Americans, investigated 9 of
95 loci (all also included in CARe) and replicated 6 [7].rs10088541





Figure 4 Fine Mapping of rs629301. Comparison of the haplotype structure in the region surrounding rs629301 (marked by an arrow) in the
CEU (A) and the YRI (B).
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CARe and PAGE drawing participants from the ARIC and
CARDIA cohorts. Of the 20 associations for which repli-
cation had not yet been attempted in an African American
cohort, we were able to evaluate 16 in HUFS. One of
these, an association between rs7941030 and TC, was
replicated in HUFS. Additionally, four other associations
that did not replicate in CARe were replicated in HUFS:
rs10401969 (CILP2/SF4) with TG, rs2081687 (CYP7A1)
with LDL, rs2972146 (IRS1) with HDL, and rs4420638
(APOE) with HDL (this association replicated in PAGE).
CARe, PAGE, and HUFS all support the association of
two loci with HDL in African Americans: rs3764261
(CETP) and rs4420638 (APOE).
Possible explanations for the lack of transferability of
findings include differences in allele frequencies (see
Additional file 1) and differences in effect sizes by popu-
lation. Wide variability between populations in the fre-
quency of risk alleles associated with a range of traits in
GWAS has been demonstrated [20]. The correlation of
effect sizes between GWAS-identified associations inEuropean compared to African ancestry populations was
only 0.27 (p = 0.2) in an evaluation of 24 SNPs with
GWAS results for both ancestral groups. In fact, for 79%
of the associations investigated, point estimates were in
the opposite direction or differed by more than twofold
in European vs. African ancestry comparisons [21]. Both
of these results favor ancestry-specific analyses.
Some of the loci highlighted in this work have known
biological functions relevant to serum lipids. STARD3,
associated with HDL, is a lipid-trafficking protein. LPL,
associated with TG, is a triglyceride hydrolase and a lig-
and factor for receptor-mediated lipoprotein uptake; muta-
tions causing LPL deficiency have been implicated in type I
hyperlipoproteinemia (NCBI: LPL, 2011). ApoE, asso-
ciated with HDL, is a main lipoprotein of the chylomicron
and is involved in the catabolism of triglyceride-rich lipo-
protein constituents; defects in the gene encoding this
protein result in familial dysbetalipoproteinemia (NCBI:
APOE, 2011). CETP, associated with HDL, plays multiple
roles in HDL metabolism and in the reverse cholesterol
transport pathway [22]. A CETP SNP (rs247617) that was
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for HDL in our discovery GWAS (Additional file 3), sug-
gesting the presence of multiple functional variants at this
locus. Based on searches of both the GWAS catalog [23]
and PubMed, only one of the top SNPs from our discovery
GWAS had been previously reported: rs247617, a variant
5 KB upstream of CETP, was also associated with HDL
among Finns [24] and African Americans of the CARe
consortium [6], with a consistent direction of effect. This
variant appears to be a significant determinant of HDL
concentration across ethnicities.
Our study has two main strengths and one main limi-
tation. First, HUFS represents the general population of
African Americans in the Washington, DC area. The
lack of selection for disease status makes this an optimal
study sample for drawing conclusions regarding transfer-
ability to a broader population of African Americans.
Second, a local replication strategy was employed to evalu-
ate transferability of the reported associations, in recogni-
tion of the well-known differences in LD structure across
the genome between African and European ancestry indi-
viduals. The main limitation of this study is the modest
sample size. In some instances, it is probable that the fail-
ure to replicate was a result of lack of power. For instance,
rs9987289 (PPP1R3B) – HDL, which was replicated in the
CARe consortium analysis, was not genotyped or imputed
in this sample, but a local SNP, rs6601299 (r2 = 0.86) was
associated in the same direction, but just above the signifi-
cance level (p = 0.07). As the previous publication is a
meta-analysis with a very large sample size, it was able to
detect small effect sizes, which would be difficult to repli-
cate in a GWAS with a more limited sample size. As a re-
sult, more accurate estimates of transferability will await
the aggregation of African ancestry GWAS into a suitably
large meta-analysis. Of the 10 replicated loci in this study,
only 1 had been previously identified in an individual
GWAS (rs3764261 and HDL in GWAS of Indian Asian
men [25,26], Finns [27], and Japanese [28]).
Conclusions
Overall, this study conducted in African Americans,
replicated 10 of the 95 loci that were identified in a
large GWAS of lipids in European ancestry popula-
tions. Together with results from previous work, there
is now support for the transferability of 42% (40/95)
of the European ancestry-identified loci to African
Americans. Notably, conclusive inferences about the
transferability of all of the previous findings are precluded
by the limitations in replication attempts conducted in
African Americans thus far in terms of relative sample size
and coverage of African ancestry genetic diversity by cur-
rently available GWAS chips. Further work in African
ancestry populations will be necessary to completely
evaluate these loci.Additional files
Additional file 1: Allele Frequency Comparison for Tested Loci that
were not Transferable.
Additional file 2: Top SNPs for GWAS of Total Cholesterol.
Additional file 3 Top SNPs for GWAS of HDL.
Additional file 4: Top SNPs for GWAS of LDL.
Additional file 5: Top SNPs for GWAS of TG.
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